123 related articles for article (PubMed ID: 30197394)
21. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
22. Gastric yolk sac tumor complicated with beta-human chorionic gonadotropin-producing metastases.
Tahara H; Hirokawa T; Oyama T; Naganuma A; Maruta S; Ban S; Yoshida K; Takagi H; Mori M
Intern Med; 2008; 47(24):2145-9. PubMed ID: 19075540
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
[TBL] [Abstract][Full Text] [Related]
24. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
25. Kidney metastasis of resected early gastric carcinoma: report of a case.
Wada Y; Yoshida K; Hihara J; Tanabe K; Ukon K
Surg Today; 2007; 37(3):248-50. PubMed ID: 17342368
[TBL] [Abstract][Full Text] [Related]
26. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
[TBL] [Abstract][Full Text] [Related]
27. [Basal cell carcinoma of prostate: a report of three cases].
Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
[TBL] [Abstract][Full Text] [Related]
28. SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.
Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
Clin Nucl Med; 2018 Apr; 43(4):225-231. PubMed ID: 29401151
[TBL] [Abstract][Full Text] [Related]
29. Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases.
Namikawa T; Tsuda S; Fujisawa K; Iwabu J; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Clin J Gastroenterol; 2018 Aug; 11(4):297-301. PubMed ID: 29500608
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
[TBL] [Abstract][Full Text] [Related]
31. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients.
Nakane Y; Okamura S; Akehira K; Boku T; Okusa T; Tanaka K; Hioki K
Cancer; 1994 Jun; 73(11):2703-8. PubMed ID: 8194009
[TBL] [Abstract][Full Text] [Related]
32. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
33. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
34. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
35. [Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Okuda T; Onda M; Tokunaga A; Teramoto T; Fujita I; Mizutani T; Kiyama T; Nishi K; Okazaki S; Kyono S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2099-102. PubMed ID: 1417017
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.
Gaspar MJ; Arribas I; Coca MC; Díez-Alonso M
Tumour Biol; 2001; 22(5):318-22. PubMed ID: 11553862
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen in gastric cancer patients.
Shimizu N; Wakatsuki T; Murakami A; Yoshioka H; Hamazoe R; Kanayama H; Maeta M; Koga S
Oncology; 1987; 44(4):240-4. PubMed ID: 3614814
[TBL] [Abstract][Full Text] [Related]
38. [A case of prostatic small cell carcinoma].
Hashimoto Y; Kimura G; Tsuboi N; Akimoto M
Hinyokika Kiyo; 2000 Jun; 46(6):425-7. PubMed ID: 10934615
[TBL] [Abstract][Full Text] [Related]
39. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Waehre H; Wanderaas EH; Paus E; Fosså SD
Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
[TBL] [Abstract][Full Text] [Related]
40. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
